Scroll Back to Top
Event

Connect with Fortrea at ESMO 2026

23–27 October 2026
Madrid, Spain
Booth #1073, Hall:10
55 Days
13 Hours

Fortrea is excited to participate in the European Society for Medical Oncology (ESMO) Congress 2026, a premier global event that brings together oncology professionals, researchers, and innovators from around the world. Join us at Booth 1073 in Hall 10 to explore how Fortrea is helping reshape the future of oncology through powerful clinical development strategies, deep therapeutic expertise, and patient-focused solutions. Whether you're advancing early-phase research or driving late-stage trials, our team is here to collaborate and support your goals.

Connect with our specialists to discuss your pipeline, explore partnership opportunities, and discover how we’re accelerating progress in cancer care—together.

During ESMO 2026, Fortrea's oncology experts will be available to discuss tailored solutions across key areas of oncology development, including:

  • Indication-specific development strategies across solid tumours, haematologic malignancies, and rare cancers
  • Precision oncology approaches, including biomarker and companion diagnostic strategies
  • Complex trial designs (basket, umbrella, platform trials)
  • Advanced therapeutic modalities, including cell therapies, gene therapies, and immuno-oncology programs
  • Pediatric oncology and rare cancer development expertise
  • Decentralised and hybrid clinical trial implementation
  • Global patient access, recruitment, and site feasibility strategies
  • Long-term follow-up, survivorship, and patient retention planning 

We look forward to seeing you in Madrid!

For More Information on ESMO 2026 visit: https://www.esmo.org/

Meet our team of trial experts

Medical team

Michael George, MD Vice President, Global Head Therapeutic Area Expertise & Delivery
Luca Cantini Luca Cantini, MD, PhD Executive medical director
Krane Huang, MD Krane Huang, MD Senior Medical Director and China Regional Head of Oncology
Carmen Bisliu Carmen Besliu, MD Senior Medical Director
Photo of Olga Bodriagova, MD, PhD Olga Bodriagova, MD, PhD

Medical Director

Jose Daniel Fanjul Fuente Jose Daniel Fanjul Fuente, MD Medical Director, Oncology
Marcin Koziej Marcin Koziej, MD Medical Director, Oncology
María García Requesens, MD María García Requesens, MD Medical Director

Strategic Delivery & Growth team

Kenneth Morrison, PhD, PMP Kenneth Morrison, PhD, PMP Executive Director Strategic Delivery & Growth (Oncology)
Alexia Paire Alexia Paire Senior Director, Strategic Delivery & Growth

Delivery team

Melissa King Melissa King Executive Director, Project Management
Héctor Herrero, CPM, Msc Héctor Herrero, CPM, Msc Senior Director, Global Project Delivery, Oncology
Lukasz Kubarek Lukasz Kubarek Senior Director, Oncology Global Project Management
Dr. Anne Himmel Dr. Anne Himmel Senior Manager, Site Engagement and Partnership Delivery

Consulting team

Carla Sterk, MPharm​ Carla Sterk Executive Strategist, Product Development and Market Access Consulting
Gordon Cummins, MS Gordon Cummins, MS Executive Director, Integrated Evidence
Matthew Wallace Matthew Wallace, MPharm, MPH Director, Value Demonstration, Fortrea Consulting

Clinical Strategy and Execution team

Dawn Williams, PhD Dawn Williams, PhD Executive Director, Head of Customer Delivery Unit Adaptive Clinical Delivery
Tuba Sahin Tuba Sahin, Pharm. Director, Clinical Functional Service Provider Delivery

Senior Leadership team

Andrew Hegedus, MBA Andrew Hegedus, MBA Chief Development Officer

ESMO 2025 Highlights: Key Insights in Oncology

Explore key takeaways from ESMO 2025, including emerging trends, innovative therapies, and insights shaping the future of oncology clinical trials.

Explore ESMO 2025 Highlights
https://maps.app.goo.gl/hfZvGjFRjUpQQStp8
Advancing Innovation in Oncology
Advancing Innovation in Oncology